Bharat Parenterals Limited

Web: bplindia.in NSE: BPLPHARMA BSE: 541096 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1550 29(2%)

Near 52W High of 1649

Volume

Open

1,646

High

1,646

Low

1,571

1,521

VWAP

52 Week High

1,649

52 Week Low

1,126

Viand Research Rating

Quality Score

26/100

Growth Score

27/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,068

No. of Shares

0.69

P/E

46.48

P/B

5.62

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.08

ROCE

Profit Growth

Listing Date

Promoter Holding

67.17%

FII Holding

0.11%

DII Holding

1.07%

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Oct 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Promoters	(0.01) 67.17%	(0.01) 67.19%	(0.01) 67.19%	(0.01) 67.19%	(0.01) 67.20%	(0.01) 67.20%	(1.91) 67.20%	(-7.91) 65.35%	(0.01) 73.27%	(-0.61) 73.27%	(0.01) 73.84%	(0.01) 73.84%	(0.01) 73.84%	(0.01) 73.84%	(0.01) 73.84%	(0.01) 73.84%	(0.01) 73.84%	(0.01) 73.84%
FIIs	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.11%	(0.01) 0.08%	(0.11) 0.08%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.51) 1.07%	(0.01) 0.54%	(0.01) 0.54%	(0.01) 0.54%	(0.01) 0.54%	(0.01) 0.54%	(0.01) 0.54%	(0.61) 0.57%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%
Public	31.65%	32.17%	32.16%	32.16%	32.15%	32.16%	32.17%	33.98%	26.72%	26.72%	26.15%	26.15%	26.16%	26.15%	26.16%	26.16%	26.15%	26.15%
No. of Shareholders	3,095	3,172	3,205	3,231	3,177	3,116	2,750	2,748	2,708	2,497	2,397	2,481	2,485	2,515	2,608	2,700	2,765	2,796

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	99.62	65.19	64.62	116	103.98	72.26	71.63	92.51	67.82	59.82	59.81	69.91	50.97	59.02	81.9	26.09	52.31	38.46	60
Sales Growth % (YoY)	-4.2%	-9.8%	-9.8%	25.4%	53.3%	20.8%	19.8%	32.3%	33.1%	1.4%	-27%	168%	-2.6%	53.5%	35.6%	-57.1%	29%	-22.4%	1.4%
Sales Growth % (QoQ)	52.8%	0.9%	-44.3%	11.6%	43.9%	0.9%	-22.6%	36.4%	13.4%	-	-14.4%	37.2%	-13.6%	-27.9%	213.9%	-50.1%	36%	-35.9%	-
Expenses	100.14	63.45	63.79	102.22	101.75	68.62	79.29	88.02	66.82	53.21	55.49	59.46	44.75	56.38	72.71	24.28	47.92	35.78	50
Operating Profit	-0.52	1.74	0.83	13.78	2.23	3.64	-7.66	4.49	1	6.61	4.32	10.45	6.22	2.64	9.19	1.81	4.39	2.68	10
OPM %	-0.52	2.67	1.28	11.88	2.14	5.04	-10.69	4.85	1.47	11.05	7.22	14.95	12.2	4.47	11.22	6.94	8.39	6.97	17
Other Income	3.63	1.33	3.53	1.06	1.93	2.94	4.21	2.54	2.64	1.26	2.6	2.1	0.31	3.48	6.41	1.54	2.19	1.31	3
Interest	2.85	2.9	3.11	3.69	3.94	3.33	2.91	2.77	1.13	0.58	0.63	0.89	0.8	0.79	0.34	0.25	0.31	0.21	0
Depreciation	8.63	8.46	8.56	8.6	8.52	8.76	9.01	9.03	3.87	1.82	1.75	1.58	1.44	1.44	1.46	1.54	1.56	1.64	2
Profit before tax	-8.37	-8.29	-7.31	2.55	-8.3	-5.51	-15.37	-4.77	-1.36	5.47	4.54	10.08	4.29	3.89	13.8	1.56	4.71	2.14	11
Tax %	-2.51	16.77	17.65	134.12	13.61	43.01	13.92	85.32	88.24	33.46	46.48	30.46	47.09	36.5	28.62	28.21	15.71	41.59	26
Net Profit	-8.16	-9.67	-8.6	-0.87	-9.44	-7.88	-17.51	-8.84	-2.56	3.64	2.43	7.01	2.27	2.47	9.85	1.12	3.97	1.25	8
Net Profit Growth % (QoQ)	15.6%	-12.4%	-888.5%	90.8%	-19.8%	55%	-98.1%	-245.3%	-170.3%	49.8%	-65.3%	208.8%	-8.1%	-74.9%	779.5%	-71.8%	217.6%	-84.4%	-
Net Profit Growth % (YoY)	13.6%	-22.7%	50.9%	90.2%	-268.7%	-316.5%	-820.6%	-226.1%	-212.8%	47.4%	-75.3%	525.9%	-42.8%	97.6%	23.1%	-	-	-	-
TTM Net Profit	-27.3	-28.58	-26.79	-35.7	-43.67	-36.79	-25.27	-5.33	10.52	15.35	14.18	21.6	15.71	17.41	16.19	14.34	13.22	9.25	0
EPS in Rs	-6.96	-6.37	-10.49	11.94	-6.86	-2.42	-11.5	1.96	-0.52	6.5	6.05	13.02	4.31	4.94	17.18	2.03	7	2.34	13.88

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Sales	345	340	261	218	212	205	228	220	137	111	124
Sales Growth %	1.5%	30.3%	19.8%	2.8%	3.6%	-10.3%	3.9%	60.7%	22.6%	-10.2%	-
Expenses	330	337	234	198	183	179	200	191	124	105	114
Operating Profit	16	4	27	20	29	25	28	29	12	7	10
OPM %	5	1	10	9	14	12	12	13	9	6	8
Other Income	10	11	5	12	7	9	11	13	7	8	5
Interest	13	13	4	3	1	1	1	1	1	1	1
Depreciation	34	35	9	6	7	6	6	6	6	6	4
Profit before tax	-21	-34	19	24	28	27	33	35	13	7	9
Tax %	27	29	44	33	25	25	26	39	29	8	31
Net Profit	-27	-44	11	16	21	20	24	21	9	7	6
Net Profit Growth %	38.6%	-500%	-31.2%	-23.8%	5%	-16.7%	14.3%	133.3%	28.6%	16.7%	-
EPS in Rs	-11.88	-18.33	24.95	28.47	36.45	35.59	42.13	37.09	15.92	12.03	11.26
Dividend Payout %	-8	-5	4	3	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity	38	-27	-5	22	-1	24	14	20	6	-2
Cash from Investing Activity	9	-137	-105	-78	-7	-43	-13	-9	-8	-2
Cash from Financing Activity	-47	156	110	61	9	10	-3	-4	4	-8
Net Cash Flow	1	-8	1	4	2	-8	-1	7	2	-11

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Equity Capital	7	7	7	7	6	6	6	6	6	6	6	6	6
Reserves	315	324	324	277	191	177	160	138	112	88	67	58	51
Borrowings	146	131	180	130	158	50	18	12	1	5	9	6	19
Other Liabilities	145	114	138	129	149	118	42	43	68	60	50	40	44
Total Liabilities	613	575	649	542	504	350	226	199	188	159	132	110	120
Fixed Assets	256	245	252	205	211	42	41	45	33	35	34	31	35
CWIP	34	30	31	25	25	99	26	0	12	1	0	0	0
Investments	6	5	5	0	0	0	11	43	0	1	1	1	0
Other Assets	317	294	360	312	268	209	148	111	142	121	98	79	85
Total Assets	613	575	649	542	504	350	226	199	188	159	132	110	120

Delivery

Delivery Data: BPLPHARMA

#	Date	1126 46% 1649	Value (Cr)	Q/T 14	Del 73	Del 0
1	4-Sep	1533	0	5	62	0
2	3-Sep	1521	0	9	97	0
3	2-Sep	1518	0	7	63	0
4	1-Sep	1507	1	11	79	1
5	31-Aug	1530	0	10	66	0
6	28-Aug	1528	0	6	63	0
7	27-Aug	1497	0	5	57	0
8	26-Aug	1541	1	12	68	1
9	25-Aug	1472	0	9	73	0
10	24-Aug	1441	0	9	68	0
11	21-Aug	1397	1	11	57	0
12	20-Aug	1295	0	26	80	0
13	19-Aug	1274	0	5	78	0
14	18-Aug	1265	0	4	58	0
15	17-Aug	1307	0	2	48	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	1,068c	21c	1.97
03-Sep	1,048c	35c	3.22
01-Sep	1,082c	7c	0.68
31-Aug	1,075c	44c	4.28
27-Aug	1,031c	10c	1.00
26-Aug	1,041c	22c	2.16
25-Aug	1,019c	12c	1.16
24-Aug	1,008c	43c	4.43
21-Aug	965c	87c	9.89
19-Aug	878c	15c	1.76
18-Aug	863c	6c	0.64
17-Aug	869c	0	0

Stock Checklist

Price is above from 52 week high low average: 81%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView